Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125725534 | 12572553 | 4 | F | 20160603 | 20160921 | 20160720 | 20160922 | EXP | GB-ROCHE-1778835 | ROCHE | 65.00 | YR | F | Y | 0.00000 | 20160922 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125725534 | 12572553 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 250 | MG | ||||||||
| 125725534 | 12572553 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | U | 0 | 6 | MG | ||||||||
| 125725534 | 12572553 | 3 | SS | EMEND | APREPITANT | 1 | Oral | U | 0 | 125 | MG | ||||||||
| 125725534 | 12572553 | 4 | C | LEUCOVORIN CALCIUM. | LEUCOVORIN CALCIUM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125725534 | 12572553 | 1 | Product used for unknown indication |
| 125725534 | 12572553 | 2 | Product used for unknown indication |
| 125725534 | 12572553 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125725534 | 12572553 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125725534 | 12572553 | Anxiety | |
| 125725534 | 12572553 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |